Taisho Pharmaceutical Co., Ltd.’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Taisho Pharmaceutical focuses on the developing cold remedies and hair regrowth cosmetic products. Read more

2 Followers on Owler
2 Followers on Owler
2 Followers on Owler
2 Followers on Owler

Taisho Pharmaceutical focuses on the developing cold remedies and hair regrowth cosmetic products. Read more

CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Founded:

1912

Status:

PrivateIndependent Company

Est. Annual Revenue
Est. Employees
Sector

Update Industry

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $10M a good estimate for Taisho Pharmaceutical Co., Ltd.'s revenue?

Acquisitions

No recent acquisitions found related to Taisho Pharmaceutical Co., Ltd.

Investments

No recent investments found related to Taisho Pharmaceutical Co., Ltd.

Taisho Pharmaceutical Co., Ltd. News

October 2, 2019Biospectrum Asia

Moberg inks deal with Taisho for anti-fungal candidate

Taisho will fund and conduct the development and registration activities in Japan... See more »
July 1, 2019The Pharma Letter

BRIEF-B-MS completes consumer health divestment

Bristol-Myers Squibb has completed the sale of its consumer health business, UPSA, to Taisho Pharmace... See more »
July 1, 2019Pharamceutical Technology

Taisho Pharmaceutical concludes acquisition of UPSA

Taisho Pharmaceutical has completed an acquisition of Bristol-Myers Squibb's (BMS) UPSA consumer heal... See more »
March 1, 2019The Pharma Letter

BRIEF - Taisho seeks to increase Duoc Hau Giang share

Japanese drugmaker Taisho Pharmaceutical has sought to increase its stake in Vietnam-based Duoc Hau G... See more »
February 17, 2019DealStreetAsia

VinaCapital pares stake in FPT; Taisho ups holding in DHG Pharma

Taisho is still cementing its position as DHG Pharma's second largest investor after the State Capita... See more »
December 17, 2018Reuters

UPDATE 1-Taisho said to near $1.6 bln deal for Bristol-Myers's UPSA- Bloomberg

* Taisho's sales of OTC drugs down year-on-year in April-Sept (Adds details on Taisho)... See more »
December 17, 2018FIRSTWORD PHARMA

report

According to sources close to the matter, Bristol-Myers Squibb is nearing a deal to sell its consumer... See more »

Taisho Pharmaceutical Co., Ltd. Press Releases

August 21, 2017PR Newswire

Key Vendors are Red Bull GmbH, Monster Energy & Rockstar

DUBLIN, August 22, 2017 /PRNewswire/ -- The "Energy Drinks Market Analysis By Product (Alcoholic/Non-... See more »
December 11, 2015Business Wire

Acute Upper Respiratory Tract Infections Global Clinical Trials Review Report, H2, 2015 - Analysis & Opportunities

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/4dlhxt/acut... See more »
June 30, 2015PRESS RELEASE POINT

ABLYNX AND TAISHO SIGN EXCLUSIVE LICENSE AGREEMENT FOR THE DEVELOPMENT AND COMMERCIALISATION OF ANTI-TNFa NANOBODY (OZORALIZUMAB) IN JAPAN

Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced that it has entered into an exclusive li... See more »
June 26, 2015PRESS RELEASE POINT

ZOSYN® Receives Approval for the Additional Indication of Febrile Neutropenia

Taiho Pharmaceutical Co., Ltd. (HQ: Tokyo, President and Representative Director: Masayuki Kobayashi)... See more »
June 3, 2015PR-INSIDE.COM

Taisho Pharmaceutical Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

(PR-inside.com) Taisho Pharmaceutical Co., Ltd. (Taisho) is a pharmaceutical company. The company car... See more »
April 7, 2015MARKETWIRED

Vernalis plc Enters Into Research Collaboration With Taisho Pharmaceutical Co., Ltd

WINNERSH, UNITED KINGDOM--(Marketwired - Apr 7, 2015) - Vernalis PLC (LSE: VER); (PINKSHEETS: VNLPY)... See more »
February 10, 2015PRESS RELEASE POINT

New Drug Application Filed for Ibandronate Sodium Hydrate Oral Agent, Bisphosphonate Antiresorptive Agent

February 10, 2015 (Tokyo) - Chugai Pharmaceutical Co., Ltd.read more... See more »

Social Media

Headquarters

3 Chome-24-1 Takada

Toshima-ku, Tōkyō Prefecture171-0033

81-3-3985-1111

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Taisho Pharmaceutical focuses on the developing cold remedies and hair regrowth cosmetic products. Taisho Pharmaceutical Co., Ltd. was founded in 1912. Taisho Pharmaceutical Co., Ltd.'s headquarters is located in Toshima-ku, Tōkyō Prefecture, JP 171-0...

Website

taisho.co.jp

Frequently Asked Questions about Taisho Pharmaceutical Co., Ltd.

  1. When was Taisho Pharmaceutical Co., Ltd. founded?

    Taisho Pharmaceutical Co., Ltd. was founded in 1912
  2. How much revenue does Taisho Pharmaceutical Co., Ltd. generate?

    Taisho Pharmaceutical Co., Ltd. generates $10M in revenue
  3. How much funding does Taisho Pharmaceutical Co., Ltd. have?

    Taisho Pharmaceutical Co., Ltd. has historically raised $0 in funding
  1. Where is Taisho Pharmaceutical Co., Ltd.'s headquarters?

    Taisho Pharmaceutical Co., Ltd.'s headquarters is in Toshima-ku Tōkyō Prefecture, JP
  2. How many employees does Taisho Pharmaceutical Co., Ltd. have?

    Taisho Pharmaceutical Co., Ltd. has 10 employees